Lippis Daniel J.
Lippis Daniel J., CVP, TAVR, reported a transaction classified as withholding at Edwards Lifesciences Corp involving 252.000000 shares for an estimated $21162.96. Reported holdings after the transaction were 33681.910300 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- May 03, 2026
- Filing date
- May 04, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
EW price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001225208-26-004909 Common Stock
- Transaction date
- May 03, 2026 Filed May 04, 2026, 11:30 PM · 1d delay
- Shares
- 252 sh $83.98 per share
- Estimated value
- -$21.1k Computed from shares × price
- Holdings after
- 33,681.9103 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-22 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
CVP, TAVR
- F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025.
- F2
This transaction was executed in multiple trades at prices ranging from $83.980 to $84.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to…
- F3
This transaction was executed in multiple trades at prices ranging from $82.540 to $83.490. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to…
0 other transactions
0 recent txs